The differential diagnosis for RCC FMS associated with TSC/mTOR mutations includes ELOC-mutated RCC, which are indistinguishable by their morphology and IHC characteristics, but show ELOC mutations and monosomy 8 [52], and a subset of ccRCCs that have more prominent fibromyomatous stroma. This evidence concerns the gene MTOR and renal cell carcinoma.